1. Home
  2. VNCE vs TCRX Comparison

VNCE vs TCRX Comparison

Compare VNCE & TCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vince Holding Corp.

VNCE

Vince Holding Corp.

HOLD

Current Price

$4.39

Market Cap

53.8M

ML Signal

HOLD

Logo TScan Therapeutics Inc.

TCRX

TScan Therapeutics Inc.

HOLD

Current Price

$1.06

Market Cap

64.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VNCE
TCRX
Founded
2002
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.8M
64.1M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
VNCE
TCRX
Price
$4.39
$1.06
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
7
Target Price
$4.88
$8.50
AVG Volume (30 Days)
256.2K
728.0K
Earning Date
02-01-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$296,250,000.00
$8,423,000.00
Revenue This Year
$4.06
$286.83
Revenue Next Year
$3.91
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.58
N/A
52 Week Low
$1.02
$0.88
52 Week High
$5.99
$3.43

Technical Indicators

Market Signals
Indicator
VNCE
TCRX
Relative Strength Index (RSI) 78.33 49.82
Support Level $4.05 $0.88
Resistance Level $4.65 $0.96
Average True Range (ATR) 0.37 0.08
MACD 0.11 0.03
Stochastic Oscillator 88.02 80.23

Price Performance

Historical Comparison
VNCE
TCRX

About VNCE Vince Holding Corp.

Vince Holding Corp is a fashion brand that is engaged in wholesale and retail delivery of luxury essentials like women's and men's apparel, women's and men's footwear, and handbags. Its offers women's collections of luxurious cashmere sweaters and silk blouses, leather and suede leggings and jackets, dresses, denim, pants, tanks and t-shirts, and a growing assortment of outerwear. It focuses on developing an elevated collection of Vince apparel and accessories to serve the luxurious need of the customer. The company manages its business in three segments namely Vince Wholesale, Vince Direct-to-consumer, and Rebecca Taylor and Parker segment. It operates its e-commerce business through its website. Majority of its revenue generated from Vince Wholesale segment.

About TCRX TScan Therapeutics Inc.

TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.

Share on Social Networks: